Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study

被引:2
|
作者
Wan, Tiantian [1 ]
Wei, Penghui [2 ]
Yao, Yong [3 ]
Liu, Hui [4 ]
Li, Jianjun [2 ]
机构
[1] Shandong First Med Univ, Dept Anesthesiol & Perioperat Med, Affiliated Hosp 1, Jinan, Shandong, Peoples R China
[2] Shandong Univ Qingdao, Dept Anesthesiol, Qilu Hosp, Qingdao, Shandong, Peoples R China
[3] Shandong Univ, Dept Crit Care Med, Qilu Hosp, Jinan, Shandong, Peoples R China
[4] Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2020年 / 26卷
关键词
1-Alkyl-2-acetylglycerophosphocholine Esterase; Carotid Stenosis; Delirium; Geriatrics; ATHEROSCLEROSIS; LYSOPHOSPHATIDYLCHOLINE; EXPRESSION; A(2);
D O I
10.12659/MSM.927763
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study was to investigate the relationships among carotid plaque (CP), serum lipoprotein-associated phospholipase (LP-PLA2), and POD in elderly patients. Material/Methods: Sixty-two elderly patients undergoing hip replacement with spinal-epidural anesthesia were divided into CP and non-CP groups based on the preoperative presence or absence of carotid atherosclerotic plaques, as assessed by ultrasound. POD was diagnosed by means of the Confusion Assessment Method (CAM). Blood samples were collected (preoperatively, postoperatively, and postoperative day 2) for the assessment of serum LP-PLA2 by enzyme-linked immunosorbent assay. The CP group was further divided into POD and no-POD subgroups based on the occurrence of POD. Results: The incidence of POD was higher in the CP group than in the non-CP group (P<0.05). While the LP-PLA2 level did not significantly differ between CP and non-CP groups preoperatively (P>0.05), it was higher in the CP group than in the non-CP group postoperatively and on postoperative day 2 (P<0.05). In the CP group, the LP-PLA2 level did not significantly differ between the subgroups preoperatively or postoperatively (P>0.05), but was significantly higher in the POD subgroup than in the no-POD subgroup on postoperative day 2 (P(0.05). Furthermore, the LP-PLA2 level on postoperative day 2 was an independent risk factor for POD (odds ratio: 1.03, 95% confidence interval: 1.00-1.07). Conclusions: The preoperative presence of carotid plaque is closely associated with a higher incidence of POD. The potential mechanism may involve the increased expression of LP-PLA2 in the serum, which can lead to plaque destabilization and subsequent inflammatory cascades.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Lipoprotein-associated phospholipase A2 (Lp-PLA2) in chronic kidney disease: Results from the RRI-CKD study
    Rajagopalan, S
    Kariisa, M
    Brook, R
    Dellegrottaglie, S
    Hinderliter, A
    Zhang, XL
    Chang, S
    Kiser, M
    Eisele, G
    Finkelstein, F
    Levin, N
    Kuhlmann, M
    Gillespie, B
    Saran, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 378A - 378A
  • [42] Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of congestive heart failure in older adults:: The cardiovascular health study
    Suzuki, Takeki
    Jenny, Nancy S.
    Solomon, Cam
    Tracy, Russell
    Nelson, Jeanenne J.
    Psaty, Bruce
    Furberg, Curt
    Cushman, Mary
    CIRCULATION, 2007, 116 (16) : 817 - 817
  • [43] Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and Cerebral Microbleeds: The Framingham Heart Study
    Romero, Jose R.
    Beiser, Alexa
    Preis, Sarah R.
    DeCarli, Charles
    Lee, Dong Young
    Pikula, Aleksandra
    Au, Rhoda
    Wang, Jimmy
    Kase, Carlos
    Wolf, Philip
    Benjamin, Emelia
    Fontes, Joao
    Irizarry, Michael
    Seshadri, Sudha
    NEUROLOGY, 2011, 76 (09) : A142 - A142
  • [44] Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) and Future Risk of Type 2 Diabetes: Results from the Cardiovascular Health Study
    Nelson, Tracy L.
    Biggs, Mary L.
    Kizer, Jorge R.
    Cushman, Mary
    Hokanson, John E.
    Furberg, Curt D.
    Mukamal, Kenneth J.
    DIABETES, 2011, 60 : A119 - A119
  • [45] Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) and Future Risk of Type 2 Diabetes: Results from the Cardiovascular Health Study
    Nelson, T. L.
    Biggs, M. L.
    Kizer, J. R.
    Cushman, M.
    Hokanson, J. E.
    Furberg, C. D.
    Mukamal, K. J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1695 - 1701
  • [46] Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits
    Chen, Jiahuan
    Zhang, Huanyu
    Li, Linquan
    Zhang, Xinwei
    Zhao, Dazhong
    Wang, Lingyu
    Wang, Jiaqi
    Yang, Ping
    Sun, Huan
    Liu, Kun
    Chen, Weiwei
    Li, Lin
    Lin, Feng
    Li, Zhanjun
    Chen, Y. Eugene
    Zhang, Jifeng
    Pang, Daxin
    Ouyang, Hongsheng
    He, Yuquan
    Fan, Jianglin
    Tang, Xiaochun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (01) : E11 - E28
  • [47] The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)) in Cardiovascular Disease
    Ikonomidis, Ignatios
    Michalakeas, Christos A.
    Lekakis, John
    Parissis, John
    Anastasiou-Nana, Maria
    REVIEWS ON RECENT CLINICAL TRIALS, 2011, 6 (02) : 108 - 113
  • [48] EVEROLIMUS REDUCES ATHEROSCLEROSIS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) SECRETION IN APOLIPOPROTEIN E KNOCKOUT MICE
    Sazonova, M. A. A. .
    Sazonova, M. D.
    Sinyov, V. V.
    Ryzhkova, A. I.
    Kirichenko, T. V.
    Doroschuk, N. A.
    Karagodin, V. P.
    Orekhov, A. N.
    Sobenin, I. A.
    ATHEROSCLEROSIS, 2021, 331 : E98 - E98
  • [49] "SI: PAF" Oxidized phospholipids and lipoprotein-associated phospholipase A2 (Lp-PLA2) in atherosclerotic cardiovascular disease: An update
    Pantazi, Despoina
    Tellis, Constantinos
    Tselepis, Alexandros D.
    BIOFACTORS, 2022, 48 (06) : 1257 - 1270
  • [50] EVEROLIMUS REDUCES ATHEROSCLEROSIS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) SECRETION IN APOLIPOPROTEIN E KNOCKOUT MICE
    Poti, F.
    Feuerborn, R.
    Busnelli, M.
    Dessena, M.
    Nofer, J. -R.
    ATHEROSCLEROSIS, 2021, 331 : E98 - E98